Medtronic plc (NYSE: MDT) is considered one of the best slow growth stocks to invest in, with Truist Securities raising its price target to $110 from $103 after the company’s fiscal second-quarter results showed revenue growth driven by Pulsed Field Ablation technology. The company’s cardiac ablation solutions division saw a 71% year-over-year organic sales increase in the same quarter, with steady growth in the CAS business due to PFA adoption. Truist noted an operating margin miss and modest rise in earnings per share expectations, attributing it to increased reinvestment ahead of significant product releases. Despite strategic investments, Medtronic’s potential for upside growth and profit acceleration is limited. As a leader in medical technology, Medtronic plc focuses on device-based therapeutics, with breakthroughs in spine and minimally invasive treatments, including robotic-assisted surgery technology. While Medtronic holds investment potential, certain AI stocks may offer greater upside potential and less downside risk. For those interested in an undervalued AI stock with potential benefits from Trump-era tariffs and onshoring trends, a free report on the best short-term AI stock is available.

Read more at Yahoo Finance: Medtronic (MDT) Price Target Raised as PFA Technology Drives Q2 Revenue Gains